Search results for "Rating scale"

showing 10 items of 537 documents

Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

2016

We analyzed the efficacy of functional remediation, in a sample of patients with bipolar disorder who presented with subsyndromal symptoms. From a total sample of 239 patients with bipolar I and II disorder, according to DSM-IV-TR diagnostic criteria, entering a randomized clinical trial, those patients who presented with subsyndromal symptoms were selected based on a method already described by Berk and colleagues was applied. It consists of using the Clinical Global Impression-Bipolar version (CGI-BP) to establish the scores of the Hamilton Depression Rating Scale (HAM-D) and of the Young Mania Rating Scale (YMRS) that correspond with 1 in the CGI-BP. Functional outcome and mood symptoms …

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentYoung Mania Rating Scalelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawmental disordersmedicinePsychoeducationHumansPharmacology (medical)Bipolar disorderBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesPharmacologyAnalysis of VarianceChi-Square DistributionMiddle Agedmedicine.diseaseCognitive Remediation030227 psychiatryPsychotherapyPsychiatry and Mental healthTreatment OutcomeMoodNeurologyPhysical therapyFemaleNeurology (clinical)PsychologyPsychosocial030217 neurology & neurosurgeryFollow-Up StudiesClinical psychologyEuropean Neuropsychopharmacology
researchProduct

Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms.

2014

Recently, Functional Remediation (FR) has proven to be effective in improving the functional outcome of euthymic bipolar patients. The aim of this study was to test the efficacy of the FR program in a subsample of euthymic bipolar II patients (BPII). A post-hoc analyses were undertaken using data of 53 BPII outpatients who had participated in a multicenter, rater-blind, randomized, controlled trial exploring the efficacy of FR (n=17) as compared with a Psychoeducation group (PSY) (n=19) and a treatment as usual control group (TAU n=17). The primary outcome variable was the functional improvement defined as the mean change in the Functioning Assessment Short Test (FAST) from baseline to endp…

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentlaw.inventionBipolar II disorderCognitionRandomized controlled triallawInternal medicinePsychoeducationmedicineHumansPharmacology (medical)Single-Blind MethodBipolar disorderBiological PsychiatryPharmacologyPsychiatric Status Rating ScalesCognitive Behavioral Therapymedicine.diseaseCognitive behavioral therapyPsychiatry and Mental healthTreatment OutcomeNeurologyCognitive remediation therapyFemaleNeurology (clinical)medicine.symptomPsychologyNeurocognitiveManiaClinical psychologyEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: results of a controlled family study.

1993

The aim of the study was to differentiate bipolar II, bipolar I and recurrent unipolar depression by their familial load for affective disorders. Eighty bipolar, 108 unipolar, 80 control subjects and interviewed first-degree relatives were diagnosed according to Research Diagnostic Criteria using the Schedule for Affective Disorders and Schizophrenia – lifetime version. The morbid risks for bipolar I disorder were equivalent in relatives of bipolar I (3.6%) and bipolar II (3.5%) subjects and lower in relatives of unipolar subjects (1.0%). The morbid risks of relatives for bipolar II disorder distinguished bipolar II subjects (6.1%) from bipolar I subjects (1.8%), from unipolar depressives (…

AdultMalemedicine.medical_specialtyBipolar I disorderBipolar DisorderAdolescentResearch Diagnostic Criteriabehavioral disciplines and activitiesDiagnosis DifferentialBipolar II disorderRisk Factorsmental disordersmedicineHumansBipolar disorderPsychiatryDepression (differential diagnoses)AgedAged 80 and overPsychiatric Status Rating ScalesDepressive DisorderSchedule for Affective Disorders and SchizophreniaMiddle Agedmedicine.diseaseControl subjectsPsychiatry and Mental healthFemalesense organsPsychologyClinical psychologyActa psychiatrica Scandinavica
researchProduct

Nonlinear analysis of sleep eeg in depression: Calculation of the largest lyapunov exponent

1995

Conventional sleep analysis according to Rechtschaffen and Kales (1968) has provided meaningful contributions to the understanding of disturbed sleep architecture in depression. However, there is no characteristic alteration of the sleep cycle, which could serve as a highly specific feature for depressive illness. Therefore, we started to investigate nonlinear properties of sleep electroencephalographic (EEG) data in order to elucidate functional alterations other than those obtained from classical sleep analysis. The application of methods from nonlinear dynamical system theory to EEG data has led to the assumption that the EEG can be treated as a deterministic chaotic process. Chaotic sys…

AdultMalemedicine.medical_specialtyChaoticSleep REMPoison controlLyapunov exponentAudiologyElectroencephalographysymbols.namesakemedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryPsychiatric Status Rating ScalesDepressive DisorderSleep Stagesmedicine.diagnostic_testEye movementElectroencephalographyGeneral MedicineMiddle AgedSleep in non-human animalsPsychiatry and Mental healthNonlinear systemsymbolsFemalePsychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study…

2010

Abstract Background Atypical antipsychotics provide better control of the negative and affective symptoms of schizophrenia when compared with conventional neuroleptics; nevertheless, their heightened ability to improve cognitive dysfunction remains a matter of debate. This study aimed to examine the changes in cognition associated with long-term antipsychotic treatment and to evaluate the effect of the type of antipsychotic (conventional versus novel antipsychotic drugs) on cognitive performance over time. Methods In this naturalistic study, we used a comprehensive neuropsychological battery of tests to assess a sample of schizophrenia patients taking either conventional (n = 13) or novel a…

AdultMalemedicine.medical_specialtyCognition disorderslcsh:RC435-571Teràpia cognitivamedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticPilot ProjectsComorbidityCognitive therapyNeuropsychological TestsTrastorns de la cogniciólcsh:PsychiatryResearch articlemedicineHumansVerbal fluency testLongitudinal StudiesAntipsychotic drugsEffects of sleep deprivation on cognitive performancePsychiatryAntipsychoticRetrospective StudiesPsychiatric Status Rating ScalesCognitionExecutive functionsmedicine.diseasePsychiatry and Mental healthTreatment OutcomeSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyAntipsicòticsEsquizofrèniaVerbal memoryCognition DisordersPsychologyAntipsychotic AgentsClinical psychologyBMC Psychiatry
researchProduct

A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depress…

2017

Abstract Background Early Improvement of depressive symptoms within two weeks of antidepressant treatment is a highly sensitive but less specific predictor of later treatment outcome. The aim of this study was to identify clinical features at treatment initiation which are associated with early improvement and non-improvement as well as to identify variables predicting non-remission in patients showing an early improvement. Methods 889 patients with a major depressive episode according to DSM-IV who had participated in an antidepressant treatment trial served as study sample. Clinical predictors (demographic variables, psychopathology, comorbid disorders) were analysed in 698 (79%) early im…

AdultMalemedicine.medical_specialtyComorbidityAvoidant personality disorderPatient ReadmissionSeverity of Illness IndexSuicidal Ideation03 medical and health sciences0302 clinical medicineRisk FactorsRating scaleInternal medicinemedicineHumansMajor depressive episodePsychiatryAtypical depressionDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyTreatment OutcomeMajor depressive disorderAntidepressantFemalemedicine.symptombusiness030217 neurology & neurosurgeryPsychopathologyJournal of Affective Disorders
researchProduct

Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.

2011

Abstract Purpose To investigate whether symptomatic remission relates to better outcomes in schizophrenia. Methods Seventy-six schizophrenia patients were assessed using measures of cross-sectional symptomatic remission, social functioning, subjective quality of life (QoL), and cognition. Results Most patients (53; 69.7%) were not in remission. Remitted patients presented significantly better social functioning, better self-reported QoL, insight, and lower levels of depressive symptoms. They also showed a non-significant trend for better executive function, processing speed and verbal memory. Conclusions Symptomatic remission may be a good indicator of better clinical status, social functio…

AdultMalemedicine.medical_specialtyCross-sectional studyNeuropsychological TestsStatistics NonparametricQuality of lifeRecurrencemedicineHumansCognitive skillPsychiatryBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesAnalysis of VarianceCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesSchizophreniaQuality of LifeSchizophreniaFemaleSchizophrenic PsychologySelf ReportVerbal memoryPsychologyCognition DisordersNeurocognitiveSocial AdjustmentClinical psychologySchizophrenia research
researchProduct

Prevalence of burnout in Polish anesthesiologists and anesthetist nursing professionals: A comparative non-randomized cross-sectional study.

2015

The purpose of the study was to assess the burnout levels in nurses ( N = 161) versus physicians ( N = 373). The levels of burnout were evaluated by the Polish adaptation of the Spanish Burnout Inventory (Cronbach’s alpha > .70). High burnout level was found in 18.63 percent nurses and 12.06 percent anesthesiologists, and critical level in 3.74 percent nurses and 5.90 percent anesthetists. There were statistically significant differences in Burnout global score, Enthusiasm toward the job, Psychological exhaustion, and Indolence subscales between nurses and physicians. No significant differences were found between sexes in any variable.

AdultMalemedicine.medical_specialtyCross-sectional studyhealth care facilities manpower and serviceseducationBurnout03 medical and health sciences0302 clinical medicineCronbach's alphaNursinghealth services administrationAnesthesiology0502 economics and businessPrevalenceMedicineHumans030212 general & internal medicineBurnout ProfessionalApplied PsychologyNurse AnesthetistsPsychiatric Status Rating Scalesbusiness.industry05 social sciencesNurse anesthetistMiddle AgedhumanitiesAnesthesiologistsCritical levelCross-Sectional StudiesFamily medicinePsychiatric status rating scalesFemalePolandbusinessbusiness.employerpsychological phenomena and processes050203 business & managementJournal of health psychology
researchProduct

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

2014

AbstractBackground:Aim was to examine depressive symptoms in acutely ill schizophrenia patients on a single symptom basis and to evaluate their relationship with positive, negative and general psychopathological symptoms.Methods:Two hundred and seventy-eight patients suffering from a schizophrenia spectrum disorder were analysed within a naturalistic study by the German Research Network on Schizophrenia. Using the Calgary Depression Scale for Schizophrenia (CDSS) depressive symptoms were examined and the Positive and Negative Syndrome Scale (PANSS) was applied to assess positive, negative and general symptoms. Correlation and factor analyses were calculated to detect the underlying structur…

AdultMalemedicine.medical_specialtyDepression scaleMedizinSeverity of Illness Index03 medical and health sciences0302 clinical medicineGermanyPrevalencemedicineHumans030212 general & internal medicinePsychiatryDepression (differential diagnoses)Depressive symptomsPsychiatric Status Rating ScalesPositive and Negative Syndrome ScaleDepressionGeneral symptomsMiddle Agedmedicine.disease030227 psychiatry3. Good healthHospitalizationAffectPsychiatry and Mental healthResearch DesignSchizophreniaAcute DiseaseGuiltSchizophreniaFemaleSchizophrenic PsychologyFactor Analysis StatisticalPsychologyPsychopathologyClinical psychologySchizophrenia spectrumEuropean Psychiatry
researchProduct

Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.

2005

Amisulpride is a clinically effective antipsychotic drug in a broad dose range with low propensity for extrapyramidal symptoms (EPS). Daily doses and plasma levels of amisulpride were analyzed within a large-scale therapeutic drug monitoring (TDM) survey to find plasma level ranges for optimized treatment under naturalistic conditions. Data of 378 schizophrenic patients treated with amisulpride (100-1550 mg) were included (40% female). Amisulpride plasma levels were analyzed at steady state; assessment comprised improvement (CGI-I) and side-effects, particularly EPS. For detection of cut-off values regarding non-response or EPS, receiver operating characteristics (ROC) curves were applied a…

AdultMalemedicine.medical_specialtyDyskinesia Drug-InducedAdolescentmedicine.drug_classStatistics as TopicAtypical antipsychoticPharmacologyGastroenterologyExtrapyramidal symptomsInternal medicineGermanymedicineHumansAmisulprideBiological PsychiatryAgedRetrospective StudiesAged 80 and overNeurologic ExaminationPsychiatric Status Rating ScalesReceiver operating characteristicmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryDopamine antagonistMiddle Agedmedicine.diseasePsychiatry and Mental healthDose–response relationshipROC CurveSchizophreniaTherapeutic drug monitoringSchizophreniaFemalemedicine.symptomAmisulprideDrug MonitoringSulpiridebusinessmedicine.drugAntipsychotic AgentsJournal of psychiatric research
researchProduct